scorecardresearch
Friday, August 15, 2025
TopicDr. Reddy

Topic: Dr. Reddy

Dr Reddy’s sees short-lived boom for Merck’s Covid pills in India

Even as oral Covid pills from Merck, Pfizer are being seen as game changers, generic drugmakers are getting a reality check that there may not be too much money on the table.

Dr Reddy’s inks licensing pact with Eli Lilly for Covid treatment drug Baricitinib

The agreement between the two firms comes days after Eli Lilly signed voluntary licensing agreements with Indian drug companies— Sun Pharma, Cipla and Lupin.

Dr. Reddy’s pushes for immediate right to sell suboxone copies

Indivior Plc’s Suboxone Film is the leading opioid addiction treatment in US.

On Camera

Trump is swinging on Russia again. What this means for Europe’s security architecture

The dynamics between Europe and Russia have gone so south that mending fences looks like an uphill task—even as the US swings between sanctions and olive branches.

Slashing GST on waste can unlock Rs 1.8 lakh crore, high tax hurting circular economy goals—CSE

Centre for Science and Environment in new report makes case for rationalising GST on waste material, saying most informal operators can’t afford high tax & it also hinders recycling.

President awards 1st set of Sarvottam Yudh Seva medals since Kargil, 7 honoured for leading Op Sindoor

This year, the Indian Air Force received four of the seven awards, followed by the Indian Army with two medals, and the Indian Navy with one. 

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.